Christine Mikail Cvijic insider trades

Open-market stock purchases and sales by Christine Mikail Cvijic, President and CFO at Neurogene Inc, from SEC Form 4 filings since Mar 8, 2012.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +109%.

Recent trades

DateStockTradeValue
Jul 7, 2026NGNE Neurogene IncSold$152K
Jul 6, 2026NGNE Neurogene IncSold$21.6K
May 6, 2026NGNE Neurogene IncSold$156K
Mar 26, 2026NGNE Neurogene IncSold$55.3K
Mar 13, 2026NGNE Neurogene IncSold$48.7K
Mar 13, 2026NGNE Neurogene IncSold$29.6K
Mar 13, 2026NGNE Neurogene IncSold$5.8K
Feb 27, 2026NGNE Neurogene IncSold$121K
Feb 20, 2026NGNE Neurogene IncBought (not open market)—
Feb 20, 2026NGNE Neurogene IncBought (not open market)—

Companies traded

  • NGNE Neurogene Inc: 1 buy, 9 sales, last Jul 7, 2026
  • AXON Axovant Sciences Ltd: other filings, last Apr 29, 2016
  • NPSP NPS Pharmaceuticals Inc: other filings, last Feb 21, 2015
  • DNDN Dendreon Corp: other filings, last Feb 10, 2014

Get free alerts when Christine Mikail Cvijic files a new trade →